Chungju community health care center
Chungju, ChoongBuk, 123456, South Korea
NCT Number: NCT01626716
Late-life depression is associated with physical limitations, greater functional impairment, increased utilization and cost of health care, and suicide. Collaborative care, linking primary and mental health specialty care, has been shown to be effective for the treatment of late-life depression in primary care settings in Western countries. The primary aim of this project is to implement a depression care management intervention, and examine its effectiveness on the depressive symptoms of older patients in Korean primary care settings. Based on chronic disease management theory and previous Collaborative care management studies in western countries, we propose to test a Depression Care Management intervention,which includes care manager to support a primary care physician of depression in their old patients. Care manager'd role are monitoring the progress of treatment, supporting patient's adherence, educating patients/ family and facilitate communication between providers. Also psychiatrists provide consultation and supervision of care managers. Using a randomized controlled design, we will examine whether the Depression care management is an effective treatment for patients with late life depression in rural Korea. The primary outcome would be the improvement of depressive symptoms of patients in primary care setting.
Looking for future studies?
Notify Me60 year and older
All sexes
Interventional
Not applicable
Chungju, ChoongBuk, 123456, South Korea
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
patients who assigned to the intervention group will take 7 times phone calls from case manager
Time frame: 3 months
HAMD (Hamilton Depression Ratind Scale) Difference HAMD score between the intervention and control group from baseline to 3 month follow-up
Time frame: 3months and 6months
HAMD (Hamilton Depression Ratind Scale) Depression response is defined by improvement 50% or more HAMD scores from baseline to each follow-up periods.
Depression remission is defined by 7 or less of HAMD score at each follow-up periods
Time frame: 3 months and 6 months
SSI (Beck's suicide ieation scale) Difference total SSI scores Between the two groups from baseline to each follow-up periods
Time frame: 3 months and 6 months
EQ5D Difference EQ5D scores Between the two groups from baseline to each follow-up periods
National Clinical Research Coordination Center, Seoul, Korea
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06062472
Anxiety, Anxiety Disorders
Taoyuan, Taiwan
View Trial DetailsNCT05462977
Affect, Alzheimer Disease
Greensboro, North Carolina, United States
View Trial DetailsNCT05136742
Behavior, Behavioral Symptoms
Cairo, Dokki, Egypt
View Trial DetailsNCT01626703
Behavior, Behavioral Symptoms
Chungju, Choongbuk, South Korea
View Trial Details